- Q1 2024 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€67.5Earnings
- Q4 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€78 (+13.87%)Earnings
- Ligand Pharmaceuticals Inc To Host Investor Day TranscriptDec 12, 2023
- Q3 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€49 (-1.21%)Earnings
- Q2 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€60 (+0.84%)Earnings
- Q1 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€68 (+0.74%)Earnings
- Q4 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2023€66.1 (-0.99%)Earnings
- Ligand Pharmaceuticals Inc Investor and Analyst Day TranscriptDec 13, 2022
- Q3 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2022€61.94 (-3.04%)Earnings
- Q2 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022€59.17 (-0.04%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2022
- Q1 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€55.04 (-2.91%)Earnings
- Q4 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 17, 2022€66.74 (-0.84%)Earnings
- Q3 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2021€81.37 (-1.18%)Earnings
- Q2 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021€64.68 (+1.67%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 04, 2021
- Q1 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2021€74.06 (-1.90%)Earnings
- Q4 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 03, 2021€93.16 (+2.79%)Earnings
- Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 15, 2020
- Q3 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2020€43.76 (-11.93%)Earnings
- Ligand Pharmaceuticals Inc Virtual Investor Day TranscriptOct 20, 2020
- Q2 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2020€63.74 (+2.32%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€57.38 (+3.26%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2020€52.52 (+0.60%)Earnings
- Q3 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019€63.15Earnings
- Q2 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2019€59.9 (-1.37%)Earnings
- Q1 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019€69.76 (-0.18%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Ligand Pharmaceuticals Inc Analyst Day TranscriptMar 12, 2019
- Ligand Pharmaceuticals Inc Announce Sale of Promacta Assets and Royalty to Royalty Pharma Call TranscriptMar 05, 2019
- Q4 2018 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019€63.24 (-2.09%)Earnings
Ligand Pharmaceuticals Inc Announce Sale of Promacta Assets and Royalty to Royalty Pharma Call Transcript
It is now my pleasure to turn today's program over to Todd Pettingill, Senior Director, Corporate Development and Investor Relations. The floor is yours.
Welcome to today's conference call to discuss Ligand's sale of Promacta royalty to Royalty Pharma. Speaking today for Ligand are John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.
As a reminder, today's call will contain forward-looking statements within the meaning of federal securities laws. These may include, but are not limited to statements regarding intent, belief or current expectations of the company and its management regarding its internal and partnered programs. These statements involve risks and uncertainties, and actual events or results may differ materially from the projections described in today's press release and this conference call. Additional information concerning risk factors and other matters concerning Ligand can be found in Ligand's earnings press release and public periodic
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)